Related Experiment Video
Updated: Mar 22, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Left Ventricular Dyssynchrony Predicts Left Main Coronary Artery Disease in Patients with Non-ST-Segment Elevation
Yueh-Juh Lin1, Kuo-Liong Chien2, Hsuan-Kuang Chen1
1Department of Cardiology, En Chu Kong Hospital;
Insights
Left ventricular dyssynchrony assessed by 3D echocardiography independently predicts left main coronary artery stenosis in non-ST-segment elevation myocardial infarction patients. This noninvasive method aids diagnosis.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Tools
Background:
- Left main coronary artery stenosis is a critical condition.
- Non-ST-segment elevation myocardial infarction (NSTEMI) requires accurate risk stratification.
- Left ventricular dyssynchrony may indicate underlying cardiac issues.
Purpose of the Study:
- To investigate if left ventricular dyssynchrony predicts left main coronary artery stenosis.
- To evaluate the utility of 3D echocardiography in identifying this stenosis.
Main Methods:
- 100 NSTEMI patients underwent 3D echocardiography and coronary angiography.
- Left ventricular dyssynchrony measured using standard deviation of time to minimal systolic volume.
- Significant stenosis defined as ≥50% in left main or ≥70% in other major coronary arteries.
Main Results:
- 3D echocardiography-derived dyssynchrony was an independent predictor of left main coronary artery stenosis (OR 1.2, p=0.04).
- Optimal cutoff value of 8.86 predicted stenosis with 71.4% sensitivity and 89.2% specificity.
- Logistic regression confirmed dyssynchrony as a significant predictor.
Conclusions:
- 3D echocardiography assessment of left ventricular dyssynchrony is a useful noninvasive diagnostic tool.
- This method can help identify left main coronary artery stenosis in NSTEMI patients.
- Findings support the integration of dyssynchrony assessment in NSTEMI evaluation.
Background:
The purpose of our study was to examine whether left ventricular dyssynchrony predicts left main coronary artery stenosis in patients with non-ST-segment elevation myocardial infarction.
Methods:
A total of 100 consecutive patients with non-ST-segment elevation myocardial infarction underwent echocardiography and coronary artery angiography. The 3-dimensional echocardiography-derived left ventricular dyssynchrony parameter was determined by using the standard deviation of the time to the minimal systolic volume for the 16 segments. A stenosis ≥ 50% of the diameter of the left main coronary artery or a stenosis ≥ 70% in 1 or more of the major epicardial vessels or their main branches was considered significant.
Results:
The logistic regression analysis revealed that this parameter (odds ratio 1.2; 95% confidence interval, 1.01-1.42; p = 0.04) was the independent predictor of left main coronary artery stenosis. The receiver operating characteristic curve analysis revealed 8.86 as the optimal cutoff value to predict left main coronary artery stenosis (sensitivity, 71.4%; specificity, 89.2%).
Conclusions:
The assessment of left ventricular dyssynchrony by 3-dimensional echocardiography is useful for a noninvasive diagnosis of the left main coronary artery stenosis in patients with non-ST-segment elevation myocardial infarction.
Key Words:
Dyssynchrony; Left main coronary artery stenosis; Non-ST-segment elevation myocardial infarction.
More Related Videos
06:34Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations